Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Rustgi

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Alimentary Pharmacology & Therapeutics|June 20, 2012
Randomised clinical trial: pre-dosing with taribavirin before starting pegylated interferon vs. standard combination regimen in treatment-naïve patients with chronic hepatitis C genotype 1M Palmer, R Rubin, V Rustgi, et al.
Journal of Medical Virology|May 1, 1993
HCV RNA in patients with chronic hepatitis C treated with interferon-alphaT J Liang, V Rustgi, E Galun, et al.
Archives of Internal Medicine|September 1, 1987
Psychiatric complications of long-term interferon alfa therapyP F Renault, J H Hoofnagle, Y Park, et al.
Annals of Internal Medicine|September 15, 1989
Glomerulonephritis caused by chronic hepatitis B virus infection: treatment with recombinant human alpha-interferonM Lisker-Melman, D Webb, A M Di Bisceglie, et al.
The New England Journal of Medicine|December 18, 1986
Treatment of chronic non-A,non-B hepatitis with recombinant human alpha interferon. A preliminary reportJ H Hoofnagle, K D Mullen, D B Jones, et al.
Gastroenterology|November 1, 1988
Randomized, controlled trial of recombinant human alpha-interferon in patients with chronic hepatitis BJ H Hoofnagle, M Peters, K D Mullen, et al.
The American Journal of Gastroenterology|October 29, 2000
Treatment of chronic hepatitis C in patients who failed interferon monotherapy: effects of higher doses of interferon and ribavirin combination therapy. The Virginia Cooperative Hepatitis Treatment GroupM L Shiffman, C M Hofmann, J Gabbay, et al.
The New England Journal of Medicine|November 20, 1998
Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C. International Hepatitis Interventional Therapy GroupG L Davis, R Esteban-Mur, V Rustgi, et al.
Journal of Viral Hepatitis|December 16, 2014
A randomized, placebo-controlled study of the NS5B inhibitor beclabuvir with peginterferon/ribavirin for HCV genotype 1H Tatum, P J Thuluvath, E Lawitz, et al.
Digestive Diseases and Sciences|January 20, 2016
Prospective Multicenter Observational Study of Overt Hepatic EncephalopathyC S Landis, M Ghabril, V Rustgi, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Alimentary Pharmacology & Therapeutics|June 20, 2012
Randomised clinical trial: pre-dosing with taribavirin before starting pegylated interferon vs. standard combination regimen in treatment-naïve patients with chronic hepatitis C genotype 1M Palmer, R Rubin, V Rustgi, et al.
Journal of Medical Virology|May 1, 1993
HCV RNA in patients with chronic hepatitis C treated with interferon-alphaT J Liang, V Rustgi, E Galun, et al.
Archives of Internal Medicine|September 1, 1987
Psychiatric complications of long-term interferon alfa therapyP F Renault, J H Hoofnagle, Y Park, et al.
Annals of Internal Medicine|September 15, 1989
Glomerulonephritis caused by chronic hepatitis B virus infection: treatment with recombinant human alpha-interferonM Lisker-Melman, D Webb, A M Di Bisceglie, et al.
The New England Journal of Medicine|December 18, 1986
Treatment of chronic non-A,non-B hepatitis with recombinant human alpha interferon. A preliminary reportJ H Hoofnagle, K D Mullen, D B Jones, et al.
Gastroenterology|November 1, 1988
Randomized, controlled trial of recombinant human alpha-interferon in patients with chronic hepatitis BJ H Hoofnagle, M Peters, K D Mullen, et al.
The American Journal of Gastroenterology|October 29, 2000
Treatment of chronic hepatitis C in patients who failed interferon monotherapy: effects of higher doses of interferon and ribavirin combination therapy. The Virginia Cooperative Hepatitis Treatment GroupM L Shiffman, C M Hofmann, J Gabbay, et al.
The New England Journal of Medicine|November 20, 1998
Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C. International Hepatitis Interventional Therapy GroupG L Davis, R Esteban-Mur, V Rustgi, et al.
Journal of Viral Hepatitis|December 16, 2014
A randomized, placebo-controlled study of the NS5B inhibitor beclabuvir with peginterferon/ribavirin for HCV genotype 1H Tatum, P J Thuluvath, E Lawitz, et al.
Digestive Diseases and Sciences|January 20, 2016
Prospective Multicenter Observational Study of Overt Hepatic EncephalopathyC S Landis, M Ghabril, V Rustgi, et al.
Pageof 1